Recent advances in polymeric microspheres for parenteral drug deliverypart 2

Expert Opinion on Drug Delivery

Volumn 9, Issue 10, 2012, Pages 1209-1223

  Mao, Shirui ^a   Guo, Chunqiang ^b   Shi, Yi ^b   Li, Luk Chiu ^b  

^a SHENYANG PHARMACEUTICAL UNIVERSITY   (China)

^b ABBOTT LABORATORIES   (United States)

Author keywords

Applications of microspheres; Delivery of biologics; Microsphere fabrication; Polymeric microspheres

Indexed keywords

ALGINIC ACID; ANTISENSE OLIGODEOXYNUCLEOTIDE; CANCER VACCINE; CARBON DIOXIDE; CYCLOPHOSPHAMIDE; CYTOCHROME P450 1B1; DEXAMETHASONE; DNA VACCINE; FIBROBLAST GROWTH FACTOR 2; GELATIN; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MALARIA VACCINE; MICROSPHERE; POLYAMIDOAMINE; POLYMER; RECOMBINANT ALPHA2B INTERFERON; RIBAVIRIN; SMALL INTERFERING RNA; SOLVENT; TRANSACTIVATOR PROTEIN; UNCLASSIFIED DRUG; VASCULOTROPIN; WART VIRUS VACCINE; ZYC 300;

ANTIGEN PRESENTING CELL; BIOCOMPATIBILITY; CELLULAR IMMUNITY; CRITICAL LIMB ISCHEMIA; DRUG DELIVERY SYSTEM; DRUG RELEASE; DRUG SAFETY; ELECTROSPRAY; EMULSION; FLU LIKE SYNDROME; GENE TARGETING; HEPATITIS C; HUMAN; HUMORAL IMMUNITY; MICROFLUIDICS; NONHUMAN; PARENTERAL DRUG ADMINISTRATION; PARTICLE SIZE; PERIPHERAL OCCLUSIVE ARTERY DISEASE; POLYMERIZATION; REVIEW; SPRAY DRYING; SUPERCRITICAL FLUID;

DRUG CARRIERS; DRUG DELIVERY SYSTEMS; GENE TRANSFER TECHNIQUES; HUMANS; MICROSPHERES; PHARMACEUTICAL PREPARATIONS; POLYMERS; PROTEINS; TECHNOLOGY, PHARMACEUTICAL; VACCINES;

EID: 84866881825     PISSN: 17425247     EISSN: 17447593     Source Type: Journal    
DOI: 10.1517/17425247.2012.717926     Document Type: Review

References (116)

1. Freiberg S, Zhu XX. Polymer microspheres for controlled drug release. Int J Pharm 2004;282(1-2):1-18
2. Berkland C, Pollauf E, Raman C, et al. Macromolecule release from monodisperse PLG microspheres: control of release rates and investigation of release mechanism. J Pharm Sci 2007;96(5):1176-91
3. Choy YB, Choi H, Kim KK. Uniform biodegradable hydrogel microspheres fabricated by a surfactant-free electric-field-assisted method. Macromol Biosci 2007;7(4):423-8
4. Kim K, Pack D.Microspheres for drug delivery. In: Ferrari M, editor-in-chief. Biomems and biomedical nanotechnology Volume I: Biological and Biomedical Nanotechnology; Lee AP, Lee LJ, editors, Springer, 233 Spring Street, New York, NY 10013, USA; 2006:19-50
5. Berkland C, Kim K, Pack DW. Fabrication of PLG microspheres with precisely controlled and monodisperse size distributions. J Control Release 2001;73(1):59-74
6. Pollauf EJ, Berkland C, Kim KK, et al. In vitro degradation of polyanhydride/polyester core-shell double-wall microspheres. Int J Pharm 2005;301(1-2):294-303
7. Berkland C, Pollauf E, Varde N, et al. Monodisperse liquid-filled biodegradable microcapsules. Pharm Res 2007;24(5):1007-13
8. Pollauf EJ, Pack DW. Use of thermodynamic parameters for design of double-walled microsphere fabrication methods. Biomaterials 2006;27(14):2898-906
9. Cooley P, Wallace D, Antohe B. Application of ink-jet printing technology to BioMEMS and microfluidic systems. JALA 2002;7(5):33-9
10. Radulescu D, Schwade N, Wawro D. Uniform paclitaxel-loaded biodegradable microspheres manufactured by ink-jet technology. Proceedings of the Winter Symposium and 11th International Symposium on Recent Advances in Drug Delivery Systems; Salt Lake City, UT, USA; 2003
11. Multilayer microspheres. MicroFab Technologies, Inc. Plano, Texas. Available from: http://www.microfab.com/index.php?option=com-content view=articleid=71Itemid=134 [Last accessed 16 July 2012]
12. Veldhuis G, Girones M, Bingham D. Monodisperse microspheres for parenteral drug delivery. Drug Deliv Technol 2009;9(1):24-31
13. Duque LF, Lathuile A, Limousin MFP, et al. Biodegradable monodisperse microspheres with sustained release of goserelin acetate for the treatment of prostate and breast cancer. Poster#
14. The 39th Annual Meeting & Exposition of the Controlled Release Society; Quebec City, Canada; 2012
15. Hiemstra C, Lathuile A, Zuidema J, et al. IGF-1 loaded monospheres for treating ischemic heart disease. Poster#
16. The 39th Annual Meeting & Exposition of the Controlled Release Society; Quebec City, Canada; 2012
17. Kang L, Chung BG, Langer R, et al. Microfluidics for drug discovery and development: from target selection to product lifecycle management. Drug Discov Today 2008;13(1-2):1-13
18. Xu Q, Hashimoto M, Dang TT, et al. Preparation of monodisperse biodegradable polymer microparticles using a microfluidic flow-focusing device for controlled drug delivery. Small 2009;5(13):1575-81
19. Palmer D, Pattison S, Cheung I, et al. Master the microsphere. PFQ;December/January 2012
20. Palmer D, Zhao X, Seaman P. Encapsulation of biotherapies: new technology for synthesis of monodisperse microspheres. PFQ; August/September 2010
21. Bae SE, Son JS, Park K, et al. Fabrication of covered porous PLGA microspheres using hydrogen peroxide for controlled drug delivery and regenerative medicine. J Control Release 2009;133(1):37-43
22. Mok H, Park TG. Water-free microencapsulation of proteins within PLGA microparticles by spray drying using PEG-assisted protein solubilization technique in organic solvent. Eur J Pharm Biopharm 2008;70(1):137-44
23. Monodisperse spray drying technology. Nanomi B.V., the Netherlands. Available from: http://www.nanomi.com/monodisperse-spray-drying-nozzle.html [Last accessed 16 July, 2012]
24. Van der Gucht F, De Ridder I; Particle engineering with a lab scale spray-dryer. ProCepT nv, Belgium. Available from: http://www.pro-c-ept.com/ files/Articles/Poster%20AAPS%202007%20Particle% 20Engineering%20with%20Spray% 20Drying.pdf [last accessed 16 July, 2012]
25. Semeels G, Van der Gucht F, Van den Mooter G; Optimization of process conditions for spray drying drug-loaded poly lactic-co-glycolic acid (PLGA) microspheres. ProCepT nv, Belgium. Available from: http://www.proc-ept.com/ files/Articles/Poster%20AAPS% 202009%20Spray%20Drying%20PLGA. pdf [Last accessed 16 July, 2012]
26. Wan F, Maltesen MJ, Bjerregaard S, et al. Design and characterization of biodegradable polymer-coated protein micropartices by spray drying method with a three-fluid nozzle. Poster#
27. The 39th Annual Meeting & Exposition of the Controlled Release Society; Quebec City, Canada; 2012
28. Bock N, Woodruff MA, Hutmacher DW, et al. Electrospraying, a reproducible method for production of polymeric microspheres for biomedical applications. Polymers 2011;3(1):131-49
29. Almeria B, DengW, Fahmy TM, et al. Controlling the morphology of electrospray-generated PLGA microparticles for drug delivery. J Colloid Interface Sci 2010;343(1):125-33
30. Xie J, Ng WJ, Lee LY, et al. Encapsulation of protein drugs in biodegradable microparticles by co-axial electrospray. J Colloid Interface Sci 2008;317(2):469-76
31. Davies OR, Lewis AL, Whitaker MJ, et al. Applications of supercritical CO2 in the fabrication of polymer systems for drug delivery and tissue engineering. Adv Drug Deliv Rev 2008;60(3):373-87
32. Baxendale AJ, van Hooff P, Durrant LG, et al. Single shot tetanus vaccine manufactured by a supercritical fluid encapsulation technology. Int J Pharm 2011;413(1-2):147-54
33. Whitaker MJ, Hao J, Davies OR, et al. The production of protein-loaded microparticles by supercritical fluid enhanced mixing and spraying. J Control Release 2005;101(1-3):85-92
34. Jordan F, Naylor A, Kelly CA, et al. Sustained release hGH microsphere formulation produced by a novel supercritical fluid technology: in vivo studies. J Control Release 2010;141(2):153-60
35. Bahrami M, Ranjbarian S. Production of micro-and nano-composite particles by supercritical carbon dioxide. J Supercrit Fluids 2007;40(2):263-83
36. Reverchon E, Adami R, Caputo G, et al. Spherical microparticles production by supercritical antisolvent precipitation: interpretation of results. J Supercrit Fluids 2008;47(1):70-84
37. Mishima K. Biodegradable particle formation for drug and gene delivery using supercritical fluid and dense gas. Adv Drug Deliv Rev 2008;60(3):411-32
38. Lee LY, Smith KA, Wang C-H. Fabrication of controlled release devices using supercritical antisolvent method. Available from: http://hdl.handle.net/ 1721.1/7479 [Last accesssed 16 July 2012]
39. Lee LY, Smith KA, Wang C-H. Fabrication of micro and nanoparticles of paclitaxel-loaded poly L lactide for controlled release using supercritical antisolvent method: effects of thermodynamics and hydrodynamics. Available from: http://hdl.handle.net/1721.1/30387 [Last accessed 16 July 2012]
40. Guan J, Ferrell N, James Lee L, et al. Fabrication of polymeric microparticles for drug delivery by soft lithography. Biomaterials 2006;27(21):4034-41
41. Guan J, Chakrapani A, Hansford DJ. Polymer microparticles fabricated by soft lithography. Chem Mater 2005;17(25):6227-9
42. Kelly JY, DeSimone JM. Shape-Specific, Monodisperse Nano-Molding of Protein Particles. JACS 2008;130(16):5438-9
43. Rolland JP, Maynor BW, Euliss LE, et al. Direct Fabrication and Harvesting of Monodisperse, Shape-Specific Nanobiomaterials. JACS 2005;127(28):10096-100
44. Canelas DA, Herlihy KP, DeSimone JM. Top-down particle fabrication: control of size and shape for diagnostic imaging and drug delivery. Wiley Interdiscip Rev Nanomed Nanobiotechnol 2009;1(4):391-404
45. Acharya G, Shin CS, McDermott M, et al. The hydrogel template method for fabrication of homogeneous nano/microparticles. J Control Release 2010;141(3):314-19
46. Lin Y, Huang Y. Laser-assisted fabrication of highly viscous alginate microsphere. J Appl Phys 2011;109(8):083107-8
47. Zhang H, Tong S-Y, Zhang X-Z, et al. Novel solvent-free methods for fabrication of nano-and microsphere drug delivery systems from functional biodegradable polymers. J Phys Chem C 2007;111(34):12681-5
48. Crespy D, Landfester K. Miniemulsion polymerization as a versatile tool for the synthesis of functionalized polymers. Beilstein J Org Chem 2010;6:1132-48
49. Zhao T, Qiu D. One-pot synthesis of highly folded microparticles by suspension polymerization. Langmuir 2011;27(21):12771-4
50. Nguyen D, Duguet E, Bourgeat-Lami E, et al. An easy way to control the morphology of colloidal polymer-oxide supraparticles through seeded dispersion polymerization. Langmuir 2010;26(9):6086-90
51. King WJ, Toepke MW, Murphy WL. A general route for the synthesis of functional, protein-based hydrogel microspheres using tailored protein charge. Chem Commun (Camb) 2011;47(1):526-8
52. Marui A, Tabata Y, Kojima S, et al. A novel approach to therapeutic angiogenesis for patients with critical limb ischemia by sustained release of basic fibroblast growth factor using biodegradable gelatin hydrogel: an initial report of the phase I-IIa study. Circ J 2007;71(8):1181-6
53. Hashimoto T, Koyama H, Miyata T, et al. Selective and sustained delivery of basic fibroblast growth factor (bFGF) for treatment of peripheral arterial disease: results of a phase I trial. Eur J Vasc Endovasc Surg 2009;38(1):71-5
54. De Leede LG, Humphries JE, Bechet AC, et al. Novel controlled-release Lemnaderived IFN-alpha2b (Locteron): pharmacokinetics, pharmacodynamics, and tolerability in a phase I clinical trial. J Interferon Cytokine Res 2008;28(2):113-22
55. Krastev Z, Kotzev I, Tchernev K, et al. Randomized, open-Label 12-Week comparison of controlled-release interffron alpha2b+ribavrin vs. pegylated-interferon alpha2b+ribavrin in treatment-naive genotype1 hepatitis C: 4 week results from 480study (panel a). J Hepatol 2010;52:S27-S
56. van Dijkhuizen-Radersma R, Metairie S, Roosma JR, et al. Controlled release of proteins from degradable poly(etherester) multiblock copolymers. J Control Release 2005;101(1-3):175-86
57. van Dijkhuizen-Radersma R, Wright SJ, Taylor LM, et al. In vitro/in vivo correlation for 14C-methylated lysozyme release from poly(ether-ester) microspheres. Pharm Res 2004;21(3):484-91
58. Park EJ, Na DH, Lee KC. In vitro release study of mono-PEGylated growth hormone-releasing peptide-6 from PLGA microspheres. Int J Pharm 2007;343(1-2):281-3
59. Lee ES, Park KH, Park IS, et al. Glycol chitosan as a stabilizer for protein encapsulated into poly(lactide-coglycolide) microparticle. Int J Pharm 2007;338(1-2):310-16
60. Lee ES, Kwon MJ, Lee H, et al. In vitro study of lysozyme in poly(lactide-coglycolide) microspheres with sucrose acetate isobutyrate. Eur J Pharm Sci 2006;29(5):435-41
61. Yeh MK, Chen JL, Chiang CH, et al. The preparation of sustained release erythropoietin microparticle. J Microencapsul 2007;24(1):82-93
62. Ho ML, Fu YC, Wang GJ, et al. Controlled release carrier of BSA made by W/O/W emulsion method containing PLGA and hydroxyapatite. J Control Release 2008;128(2):142-8
63. Chan OC, So KF, Chan BP. Fabrication of nano-fibrous collagen microspheres for protein delivery and effects of photochemical crosslinking on release kinetics. J Control Release 2008;129(2):135-43
64. Solorio L, Zwolinski C, Lund AW, et al. Gelatin microspheres crosslinked with genipin for local delivery of growth factors. J Tissue Eng Regen Med 2010;4(7):514-23
65. Jay SM, Saltzman WM. Controlled delivery of VEGF via modulation of alginate microparticle ionic crosslinking. J Control Release 2009;134(1):26-34
66. Wang X, Wenk E, Hu X, et al. Silk coatings on PLGA and alginate microspheres for protein delivery. Biomaterials 2007;28(28):4161-9
67. Yu CY, Yin BC, Zhang W, et al. Composite microparticle drug delivery systems based on chitosan, alginate and pectin with improved pH-sensitive drug release property. Colloids Surf B Biointerfaces 2009;68(2):245-9
68. Yuan W, Wu F, Guo M, et al. Development of protein delivery microsphere system by a novel S/O/O/W multi-emulsion. Eur J Pharm Sci 2009;36(2-3):212-18
69. Lee JI, Yoo HS. Biodegradable microspheres containing poly(epsiloncaprolactone)-Pluronic block copolymers for temperature-responsive release of proteins. Colloids Surf B Biointerfaces 2008;61(1):81-7
70. King WJ, Pytel NJ, Ng K, et al. Triggered drug release from dynamic microspheres via a protein conformational change. Macromol Biosci 2010;10(6):580-4
71. Yin R, Han J, Zhang J, et al. Glucose-responsive composite microparticles based on chitosan, concanavalin A and dextran for insulin delivery. Colloids Surf B Biointerfaces 2010;76(2):483-8
72. Choleris E, Little SR, Mong JA, et al. Microparticle-based delivery of oxytocin receptor antisense DNA in the medial amygdala blocks social recognition in female mice. Proc Natl Acad Sci USA 2007;104(11):4670-5
73. Soderquist RG, Sloane EM, Loram LC, et al. Release of plasmid DNA-encoding IL-10 from PLGA microparticles facilitates long-term reversal of neuropathic pain following a single intrathecal administration. Pharm Res 2010;27(5):841-54
74. De Stefano D, De Rosa G, Maiuri MC, et al. Oligonucleotide decoy to NF-kappaB slowly released from PLGA microspheres reduces chronic inflammation in rat. Pharmacol Res 2009;60(1):33-40
75. Dass CR, Contreras KG, Dunstan DE, et al. Chitosan microparticles encapsulating PEDF plasmid demonstrate efficacy in an orthotopic metastatic model of osteosarcoma. Biomaterials 2007;28(19):3026-33
76. Davies OR, Head L, Armitage D, et al. Surface modification of microspheres with steric stabilizing and cationic polymers for gene delivery. Langmuir 2008;24(14):7138-46
77. Zhang XQ, Intra J, Salem AK. Comparative study of poly (lactic-coglycolic acid)-poly ethyleneimine-plasmid DNA microparticles prepared using double emulsion methods. J Microencapsul 2008;25(1):1-12
78. Kakade S, Manickam DS, Handa H, et al. Transfection activity of layer-by-layer plasmid DNA/poly (ethylenimine) films deposited on PLGA microparticles. Int J Pharm 2009;365(1-2):44-52
79. Intra J, Salem AK. Fabrication, characterization and in vitro evaluation of poly(D,L-lactide-co-glycolide) microparticles loaded with polyamidoamine-plasmid DNA dendriplexes for applications in nonviral gene delivery. J Pharm Sci 2010;99(1):368-84
80. Fu HL, Li YQ, Shao L, et al. Gene expression mediated by dendrimer/DNA complexes encapsulated in biodegradable polymer microspheres. J Microencapsul 2010;27(4):345-54
81. Zhang XQ, Intra J, Salem AK. Conjugation of polyamidoamine dendrimers on biodegradable microparticles for nonviral gene delivery. Bioconjug Chem 2007;18(6):2068-76
82. Tomioka A, Tanaka M, De Velasco MA, et al. Delivery of PTEN via a novel gene microcapsule sensitizes prostate cancer cells to irradiation. Mol Cancer Ther 2008;7(7):1864-70
83. Lin X, Jo H, Ishii TM, et al. Controlled release of matrix metalloproteinase-1 plasmid DNA prevents left ventricular remodeling in chronic myocardial infarction of rats. Circ J 2009;73(12):2315-21
84. Parsa S, Wang Y, Fuller J, et al. A comparison between polymeric microsphere and bacterial vectors for macrophage P388D1 gene delivery. Pharm Res 2008;25(5):1202-8
85. Sezer AD, Akbuga J. Comparison on in vitro characterization of fucospheres and chitosan microspheres encapsulated plasmid DNA (pGM-CSF): formulation design and release characteristics. AAPS PharmSciTech 2009;10(4):1193-9
86. Frechet JMJ, Cohen JL, Schubert S, et al. Acid-degradable cationic dextran particles for the delivery of siRNA therapeutics. Bioconjug Chem 2011;22(6):1056-65
87. Brandhonneur N, Chevanne F, Vie V, et al. Specific and non-specific phagocytosis of ligand-grafted PLGA microspheres by macrophages. Eur J Pharm Sci 2009;36(4-5):474-85
88. Bradley M, Alexander L, Sanchez-Martin RM. Cellular uptake of fluorescent labelled biotin-streptavidin microspheres. J Fluoresc 2008;18(3-4):733-9
89. Alexander LM, Sanchez-Martin RM, Bradley M. Knocking (anti)-sense into cells: the microsphere approach to gene silencing. Bioconjug Chem 2009;20(3):422-6
90. Wang D, Molavi O, Lutsiak ME, et al. Poly(D,L-lactic-co-glycolic acid) microsphere delivery of adenovirus for vaccination. J Pharm Pharm Sci 2007;10(2):217-30
91. Ahire VJ, Sawant KK, Doshi JB, et al. Chitosan microparticles as oral delivery system for tetanus toxoid. Drug Dev Ind Pharm 2007;33(10):1112-24
92. Torres MP, Wilson-Welder JH, Lopac SK, et al. Polyanhydride microparticles enhance dendritic cell antigen presentation and activation. Acta Biomater 2011;7(7):2857-64
93. Gunbeyaz M, Faraji A, Ozkul A, et al. Chitosan based delivery systems for mucosal immunization against bovine herpesvirus 1 (BHV-1). Eur J Pharm Sci 2010;41(3-4):531-45
94. Mata E, Igartua M, Hernández RM, et al. Comparison of the adjuvanticity of two different delivery systems on the induction of humoral and cellular responses to synthetic peptides. Drug Deliv 2010;17(7):490-9
95. Thomas C, Gupta V, Ahsan F. Particle size influences the immune response produced by hepatitis B vaccine formulated in inhalable particles. Pharm Res 2010;27(5):905-19
96. Román BS, Irache JM, Gómez S, et al. Co-encapsulation of an antigen and CpG oligonucleotides into PLGA microparticles by TROMS technology. Eur J Pharm Biopharm 2008;70(1):98-108
97. Foged C, Brodin B, Frokjaer S, et al. Particle size and surface charge affect particle uptake by human dendritic cells in an in vitro model. Int J Pharm 2005;298(2):315-22
98. Yoshida M, Babensee JE. Differential effects of agarose and poly(lactic-coglycolic acid) on dendritic cell maturation. J Biomed Mater Res A 2006;79A(2):393-408
99. Schliehe C, Schliehe C, Thiry M, et al. Microencapsulation of inorganic nanocrystals into PLGA microsphere vaccines enables their intracellular localization in dendritic cells by electron and fluorescence microscopy. J Control Release 2011;151(3):278-85
100. Yoshida M, Babensee JE. Molecular aspects of microparticle phagocytosis by dendritic cells. J Biomater Sci Polym Ed 2006;17(8):893-907
101. Waeckerle-Men Y, Groettrup M. PLGA microspheres for improved antigen delivery to dendritic cells as cellular vaccines. Adv Drug Deliv Rev 2005;57(3):475-82
102. Luby TM. Targeting cytochrome P450 CYP1B1 with a therapeutic cancer vaccine. Expert Rev Vaccines 2008;7(7):995-1003
103. Gribben JG, Ryan DP, Boyajian R, et al. Unexpected association between induction of immunity to the universal tumor antigen CYP1B1 and response to next therapy. Clin Cancer Res 2005;11(12):4430-6
104. Barbon CM, Baker L, Lajoie C, et al. In vivo electroporation enhances the potency of poly-lactide co-glycolide (PLG) plasmid DNA immunization. Vaccine 2010;28(50):7852-64
105. MatijevicM, HedleyML, Urban RG, et al. Immunization with a poly (lactide co-glycolide) encapsulated plasmid DNA expressing antigenic regions of HPV 16 and 18 results in an increase in the precursor frequency of T cells that respond to epitopes from HPV 16, 18, 6 and 11. Cell Immunol 2011;270(1):62-9
106. Pan CH, Nair N, Adams RJ, et al. Dose-dependent protection against or exacerbation of disease by a polylactide glycolide microparticle-adsorbed, alphavirus-based measles virus DNA vaccine in rhesus macaques. Clin Vaccine Immunol 2008;15(4):697-706
107. Liman M, Peiser L, Zimmer G, et al. A genetically engineered prime-boost vaccination strategy for oculonasal delivery with poly(d,l-lactic-co-glycolic acid) microparticles against infection of turkeys with avian Metapneumovirus. Vaccine 2007;25(46):7914-26
108. Singh M, Fang J-H, Kazzaz J, et al. A modified process for preparing cationic polylactide-co-glycolide microparticles with adsorbed DNA. Int J Pharm 2006;327(1-2):1-5
109. Wischke C, Borchert HH, Zimmermann J, et al. Stable cationic microparticles for enhanced model antigen delivery to dendritic cells. J Control Release 2006;114(3):359-68
110. Nguyen DN, Raghavan SS, Tashima LM, et al. Enhancement of poly (orthoester) microspheres for DNA vaccine delivery by blending with poly(ethylenimine). Biomaterials 2008;29(18):2783-93
111. Liu S, Danquah MK, Forde GM, et al. Microparticle-mediated gene delivery for the enhanced expression of a 19-kDa fragment of merozoite surface protein 1 of Plasmodium falciparum. Biotechnol Prog 2010;26(1):257-62
112. Pai Kasturi S, Qin H, Thomson KS, et al. Prophylactic anti-tumor effects in a B cell lymphoma model with DNA vaccines delivered on polyethylenimine (PEI) functionalized PLGA microparticles. J Control Release 2006;113(3):261-70
113. Spearman P, Lally MA, Elizaga M, et al. A trimeric, V2-deleted HIV-1 envelope glycoprotein vaccine elicits potent neutralizing antibodies but limited breadth of neutralization in human volunteers. J Infect Dis 2011;203(8):1165-73
114. Singh M, Kazzaz J, Chesko J, et al. Anionic microparticles are a potent delivery system for recombinant antigens from Neisseria meningitidis serotype B. J Pharm Sci 2004;93(2):273-82
115. Chesko J, Kazzaz J, Ugozzoli M, et al. Characterization of antigens adsorbed to anionic PLG microparticles by XPS and TOF-SIMS. J Pharm Sci 2008;97(4):1443-53
116. Caputo A, Castaldello A, Brocca-Cofano E, et al. Induction of humoral and enhanced cellular immune responses by novel core-shell nanosphereand microsphere-based vaccine formulations following systemic and mucosal administration. Vaccine 2009;27(27):3605-15